In our material, NRF3 expression was not associated with any tested clinical or pathological parameters or traditional prognostic factors of melanoma, but the cases retaining high NRF3 protein expression in their primary tumours had a poorer melanoma-specific survival compared to low expressors. The gene discussed is NFE2L3; the disease is neoplasm.